NABI Biopharmaceuticals

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
NABI Biopharmaceuticals
TickerVXRT
CIK #0000072444
CUSIP92243A200
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address12276 Wilkins Avenue, Rockville, MD 20852
Source [EDGAR]
CIK Filing 2011 - 2024
[0000072444] 10-K
[0000072444] 10-Q
[0000072444] 3
[0000072444] 4
[0000072444] 8-K
[0000072444] SC 13D
[0000072444] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Vanguard Group Inc Vaxart Inc [2023-02-09] 5.35
BlackRock Inc Vaxart Inc [2022-02-07] 6.7
State Street Corp Vaxart Inc [2021-02-11] 8.63
Armistice Capital LLC Vaxart Inc [2019-10-01] 62.6
Sabby Management LLC Vaxart Inc [2019-04-25] 5.01
BML Investment Partners LP Vaxart Inc [2019-04-17] 0.7
Care Capital III LLC Vaxart Inc [2018-02-23] 39.4
Krensavage Asset Management LLC Aviragen Therapeutics Inc [2018-02-15] 5.93
East Hill Management Company LLC Aviragen Therapeutics Inc [2018-02-14] 7.5
Digirad Corp Aviragen Therapeutics Inc [2017-12-29] 1.0
SC Fundamental Value Fund LP Aviragen Therapeutics Inc [2017-06-30] 11.0
East Hill Management Company LLC Aviragen Therapeutics Inc [2017-06-19] 7.9
Krensavage Asset Management LLC Aviragen Therapeutics Inc [2017-02-14] 5.9
Senzar Asset Management LLC Biota Pharmaceuticals Inc [2016-01-15] 5.2
Broadfin Capital LLC Biota Pharmaceuticals Inc [2014-08-08] 7.01
State Street Corp Biota Pharmaceuticals Inc [2014-02-05] 0.1
[2012-12-05] None
Hunter Hall Investment Management Ltd Biota Pharmaceuticals Inc [2012-11-29] 11.63
Xstelos Holdings Inc NABI Biopharmaceuticals [2012-10-17] 7.6
Mangrove Partners Fund LP NABI Biopharmaceuticals [2012-10-09] 5.97
Gamco Investors Inc ET AL NABI Biopharmaceuticals [2012-09-28] 0.54
Mangrove Partners Fund LP NABI Biopharmaceuticals [2012-06-29] 6.9
Mangrove Partners Fund LP NABI Biopharmaceuticals [2012-05-02] 5.65
Form 3/4/5 Filer 2011 - 2024
Vaxart, Inc.
Lee Phillip E
Floroiu Cezar Andrei
Cummings James F.
Tucker Sean
Berg Edward B
Watson W. Mark
Yedid Robert A.
Heron Elaine J
Wheadon David E.
Davis Todd C
Cherrington Julie M
Finney Michael J.
Ahmad Fuad
Echerd Margaret
Wilson Karen J
Latour Wouter
Boyd Steven
Armistice Capital LLC
Armistice Capital Master Fund Ltd.
Maher Illya Keith
Richard John P
Cox Geoffrey F
Vanlent Anne
Markham Richard J
Harland John M
Care Capital Investments III L.P.
Care Capital III LLC
Care Capital Offshore Investments III LP
Leschly Jan
Life Science Angel Investors III, LLC
Anido Armando
Dougherty Michael R
Dunne Michael W.
Plumb Russell H
Colonnese Mark P
Patti Joseph M
Azzarello Peter
Fox James
Hill Richard James
Errington Jeffery
Cook Peter Chapman
Gust Ian D.
Bell Paul Ronald
Kessler Paul D.
Form 13F Holdings
Firm Period DFND Voting Shares
BlackRock Inc. [2023-03-31] SOLE 8,671,669.0 8,818,647.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 6,926,711.0
Geode Capital Management LLC [2023-03-31] DFND 2,662,473.0 2,662,473.0
State Street Corp [2023-03-31] DFND 2,536,929.0 2,653,619.0
Nuveen Asset Management LLC [2023-03-31] DFND 2,219,532.0 2,219,532.0
Two Sigma Investments LP [2023-03-31] SOLE 1,194,023.0 1,194,023.0
Northern Trust Corp [2023-03-31] DFND 16,014.0 1,122,388.0
Two Sigma Advisers LP [2023-03-31] SOLE 1,074,200.0 1,099,500.0
Charles Schwab Investment Management Inc [2023-03-31] SOLE 993,223.0 993,223.0
D. E. Shaw & Co., Inc. [2023-03-31] DFND 970,590.0 981,383.0
Citadel Advisors LLC [2023-03-31] DFND 735,750.0 735,750.0
Morgan Stanley [2023-03-31] DFND 457,269.0 502,941.0
Bank of New York Mellon Corp [2023-03-31] DFND 378,131.0 449,046.0
Bank of America Corp /DE/ [2023-03-31] DFND 24,271.0 309,176.0
IHT Wealth Management LLC [2023-03-31] SOLE 442.0 261,223.0
Raymond James Financial Services Advisors Inc [2023-03-31] SOLE 0.0 212,004.0
RhumbLine Advisers [2023-03-31] SOLE 79,877.0 192,078.0
AllianceBernstein LP [2023-03-31] DFND 191,100.0 191,100.0
Ergoteles LLC [2023-03-31] SOLE 168,791.0 168,791.0
Deutsche Bank AG [2023-03-31] DFND 95,652.0 155,995.0
Goldman Sachs Group Inc [2023-03-31] DFND 139,402.0 139,402.0
Vanguard Group Inc [2023-03-31] DFND 0.0 137,175.0
Private Portfolio Partners LLC [2023-03-31] SOLE 0.0 108,970.0
Point72 Asset Management LP [2023-03-31] DFND 0.0 103,039.0
Price T Rowe Associates Inc /MD/ [2023-03-31] DFND 101,980.0 101,980.0
JPMorgan Chase & Co [2023-03-31] DFND 450.0 98,951.0
Susquehanna International Group LLP [2023-03-31] DFND 72,279.0 98,679.0
New York State Common Retirement Fund [2023-03-31] SOLE 77,529.0 77,529.0
Millennium Management LLC [2023-03-31] SOLE 75,872.0 75,872.0
Invesco Ltd. [2023-03-31] DFND 0.0 72,586.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com